Clementino Ibeas Bih
About Clementino Ibeas Bih
Clementino Ibeas Bih is a molecular biologist currently pursuing a PhD at the School of Pharmacy, University of Reading, with a focus on molecular biology. He has worked at Meiragtx in New York and Lincolnshire, United Kingdom, since 2019, combining his professional work with academic research.
Work at MeiraGTx
Clementino Ibeas Bih has been employed at MeiraGTx since 2019, serving as a Molecular Biologist. His role involves contributing to the company's research and development efforts in gene therapy. MeiraGTx is known for its innovative approaches in the field of genetic medicine, and Ibeas Bih's work supports the company's mission to advance therapeutic options for patients.
Education and Expertise
Clementino Ibeas Bih is currently pursuing a PhD at the School of Pharmacy, University of Reading. His academic focus is on molecular biology, which complements his professional experience in the field. This combination of education and hands-on work equips him with a robust understanding of molecular mechanisms and their applications in therapeutic contexts.
Background
Clementino Ibeas Bih has a background in molecular biology, which has shaped his career trajectory. His professional journey includes a blend of academic research and practical applications in the biotechnology sector. This dual experience enhances his contributions to the field and informs his ongoing studies.
Research Involvement
In addition to his role at MeiraGTx, Clementino Ibeas Bih has been involved in academic research. This involvement allows him to stay at the forefront of molecular biology advancements and integrate new findings into his work. His research activities complement his professional responsibilities and contribute to the broader scientific community.